Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

The domino of potential unethical side effects justifies a ban on germline editing.

Sarah Ruth Bates Rewriting Our Genes Is Easier Than Ever. That Doesn't Mean We Should Do It January 03, 2020 https://www.wbur.org/cognoscenti/2020/01/03/germline-prime-gene-editing-sarah-ruth-bates

That argument pushes us towards a risk we shouldn’t take. “Prime-Editing” is more precise than CRISPR, but that doesn’t make it “safe” for this purpose. If germline gene editing goes wrong, there’s no ethically sound way to stop the resulting domino effect. Gone wrong, germline gene editing has the potential to do widespread damage. Consider the recent that all living human beings descended from one woman who lived in the area we now call Botswana. Scientists have referred to this common ancestor as “Mitochondrial Eve.” Take her as an example — an extreme, but real, example — of the potential reach of one individual’s genes. Editing an embryo’s germline genes means that you’re altering the genetic code of that person, for life — and, if that individual has a baby, they may pass on those altered genes to that baby. If Nana or Lulu have children, they’ll pass on the germline edits Dr. He made — both the intended and the unintended. When they come of age, Nana and Lulu will have to have a version of the “where babies come from?” talk that no human being has ever before experienced, or should have to. The only way to prevent the future transmission of germline edits is to prevent the person whose genes have been edited from reproducing. Nana and Lulu couldn’t have possibly consented to that as a condition of the experiment, because they weren’t alive when the experiment was performed. Limiting their reproductive possibilities in that way would approach eugenics.

Its unethical – too much uncertainty – the complications might not surface for years.

Lanphier, et.al. 2015 Edward Lanphier, Fyodor Urnov, Sarah Ehlen Haecker, Michael Werner & Joanna Smolenski Published: 12 March 2015 Don’t edit the human germ line Nature volume 519, pages410–411 (2015)Ci https://www.nature.com/articles/519410a

The CRISPR technique has dramatically expanded research on genome editing. But we cannot imagine a situation in which its use in human embryos would offer a therapeutic benefit over existing and developing methods. It would be difficult to control exactly how many cells are modified. Increasing the dose of nuclease used would increase the likelihood that the mutated gene will be corrected, but also raise the risk of cuts being made elsewhere in the genome. In an embryo, a nuclease may not necessarily cut both copies of the target gene, or the cell may start dividing before the corrections are complete, resulting in a genetic mosaic. Studies using gene-editing in animals such as rats, cattle, sheep and pigs, indicate that it is possible to delete or disable genes in an embryo — a simpler process than actually correcting DNA sequences — in onlysome of the cells. The current ability to perform quality controls on only a subset of cells means that the precise effects of genetic modification to an embryo may be impossible to know until after birth. Even then, potential problems may not surface for years. Established methods, such as standard prenatal genetic diagnostics or in vitro fertilization (IVF) with the genetic profiling of embryos before implantation, are much better options for parents who both carry the same mutation for a disease.

Sign in to recut, update, or save this card.